Organ Preservation Market by Solution Type (UW, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidneys, Liver, Heart), End User (Transplant Centers, Hospitals, Specialty Clinics) - Global Forecast to 2030

icon1
USD 0.36 BN
MARKET SIZE, 2030
icon2
CAGR 6.8%
(2025-2030)
icon3
235
REPORT PAGES
icon4
195
MARKET TABLES

OVERVIEW

Organ Preservation Market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The organ preservation market is projected to reach USD 0.36 billion by 2030, from USD 0.26 billion in 2025, with a CAGR of 6.8%. The market is experiencing strong growth due to increasing incidences of chronic diseases, organ failure, and advancements in transplantation procedures. Rising rates of end-stage organ conditions, such as kidney, liver, and heart failure, along with a growing global demand for transplants, are other key factors driving market expansion. The aging population, which is more prone to organ dysfunction, further emphasizes the need for effective preservation methods to maintain organ viability before transplantation.

KEY TAKEAWAYS

  • BY SOLUTION
    The UW solution segment holds the largest market share because of its effectiveness in flushing and preserving organs such as the kidneys, liver, and pancreas. Known as the standard for intracellular preservation, UW Solution’s widespread use comes from its inclusion of inert components like lactobionate and raffinose. These substances help reduce tissue damage and support better organ function, improving transplant success rates compared to other preservation methods.
  • BY TECHNIQUE
    The static cold storage segment holds the largest market share. This traditional method is widely used and regarded as the standard for organ preservation because it can induce hypothermia, which reduces metabolic activity in donor organs. It is commonly used for preserving kidneys, liver, lungs, pancreas, and heart.
  • BY ORGAN TYPE
    The kidney segment has the largest market share, mainly due to the increasing rate of end-stage renal disease (ESRD), for which kidney transplantation remains the most effective treatment option. As cases of kidney failure continue to rise, so does the number of transplant procedures, highlighting the need for efficient preservation of donor kidneys before implantation.
  • BY END USER
    The organ transplant centers segment holds the largest market share. This growth can be attributed to the widespread development of healthcare facilities that operate dedicated transplant programs. These centers are crucial in performing organ retrieval, preservation, and transplantation, making them key consumers of preservation products and technologies.
  • BY REGION
    The rapid growth of the Asia Pacific region is due to supportive government policies, increased public awareness about organ donation, and a surge in donation activities. Countries like China and Japan have established standardized national guidelines for organ donation and transplantation, which are crucial in advancing the market. Furthermore, improvements in healthcare infrastructure, the growing burden of chronic illnesses, and the rise of medical tourism across many Asia Pacific countries are expected to drive market growth during the forecast period.
  • COMPETITIVE LANDSCAPE
    The major market players have employed both organic and inorganic strategies, including partnerships, collaborations, and approvals. For example, in March 2025, TransMedics launched its National OCS Program (NOP) in additional US states, enhancing nationwide logistics and transplant coordination for heart, lung, and liver transplants through its proprietary normothermic technology platform.

The organ preservation market is mainly driven by the increasing need for organ transplants, the rising frequency of organ failure caused by chronic conditions such as diabetes, hypertension, and kidney disease, and the growing number of road accidents and trauma cases worldwide. However, limited donor organ availability and high costs related to preservation techniques and equipment continue to hinder wider market growth.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The organ preservation market is experiencing significant change driven by global healthcare needs, increasing transplantation demand, and evolving regulations. Rising cases of organ failure, expanding transplant waiting lists, and shortages of viable donor organs are putting more pressure on healthcare systems. At the same time, growing use of normothermic machine perfusion (NMP), controlled hypothermic transport methods, and AI-powered viability assessment tools is transforming how organs are preserved, evaluated, and used. Rising healthcare costs, tighter compliance standards, and regional differences in organ donation rates are affecting procurement and adoption patterns. Sustainability efforts are encouraging the development of reusable, eco-friendly preservation systems, while digital integration enables real-time monitoring and predictive analytics to improve graft utilization. International competition, along with localization strategies, is influencing pricing and distribution, especially in emerging markets. These changes collectively prompt hospitals, transplant centers, and procurement agencies to seek solutions that extend preservation times, enhance graft quality, and maximize donor organ use, aiming for better patient outcomes while meeting cost, regulatory, and sustainability objectives.

Organ Preservation Market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Growing burden of chronic diseases
  • Increasing initiatives to promote public awareness and encourage organ donation
RESTRAINTS
Impact
Level
  • High cost of organ transplantation
  • Religious concerns and misconceptions associated with organ donation
OPPORTUNITIES
Impact
Level
  • Increasing healthcare investments
CHALLENGES
Impact
Level
  • Significant gap between number of organs donated and organs required annually
  • Development of artificial organs

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Growing burden of chronic diseases

The increasing burden of chronic diseases, trauma, and end-stage organ failure has become a major driver for the growth of the organ preservation market. As the global demand for organ transplants continues to rise, fueled by higher rates of conditions like kidney, liver, and heart failure, there is a concurrent need for reliable and effective preservation solutions to keep organs viable during storage and transport. This rise in transplantation procedures has highlighted the crucial role of innovative preservation technologies and solutions. The market has seen a growing use of specialized preservation solutions such as UW (University of Wisconsin) solution, Custodiol HTK, and others, which are essential in maintaining the structural and functional integrity of donor organs. These solutions are key in reducing ischemic damage and increasing transplantation success rates.

Restraint: High cost of organ transplantation

Organ transplantation is a complex and costly medical procedure that involves multiple high-value components, including skilled surgeons, specialized transportation, and expensive medications. The total costs, which include hospital stays, organ retrieval and preservation, as well as post-operative care and immunosuppressive therapies, significantly increase the financial burden on patients. Beyond medical expenses, patients often face additional costs for travel, accommodation, meals, diagnostic tests, and follow-up visits at transplant centers, especially during extended observation periods. These expenses can be prohibitive for patients from low-income backgrounds, who may need to prioritize basic needs like housing, food, and clothing, making organ transplants largely inaccessible without external financial support.

Opportunity: Increasing healthcare investments

Governments worldwide are prioritizing the improvement of healthcare infrastructure to provide more comprehensive and accessible medical services. For instance, in India, the Brihanmumbai Municipal Corporation (BMC) allocated ~USD 924 million (INR 7,000 crore), or 15% of its 2022–2023 budget, to enhance healthcare delivery systems. This funding aims to establish 100 healthcare centers and support over 100 types of diagnostic tests focused on preventive and primary care within BMC jurisdictions. These infrastructure developments are expected to significantly increase the number of healthcare facilities capable of managing brain-dead patients who could become organ donors. Additionally, expanding diagnostic laboratories is likely to streamline essential pre-transplant procedures such as donor-recipient matching, genetic profiling, and other diagnostic assessments.

Challenge: Significant gap between number of organs donated and organs required annually

A significant gap exists between the yearly demand for organs and the number of successful donations. As of January 2022, over 100,000 patients in the US were waiting for organs, yet only 41,354 transplants took place in 2021 (Source: Organ Procurement and Transplantation Network, US). This gap is mainly caused by limited public awareness, insufficient legislation, and the increased risk of organ trafficking. Governments are actively working to address this by enacting reformed laws, such as opt-out donation systems, and launching various initiatives to promote organ donation.

Organ Preservation Market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Ex vivo lung perfusion (EVLP) systems for lung transplantation Extends preservation time, allows assessment of marginal donor lungs, improves transplant outcomes
SherpaPak cardiac and lung transport systems using controlled hypothermic preservation Stable temperature control, reduces ischemic injury, improves graft survival rates
Organ care system for heart, lung, and liver – portable normothermic perfusion Maintains organs in near-physiologic state, increases viable donor pool, reduces post-transplant complications
Preservation solutions (Belzer UW, HTK) for liver, kidney, and pancreas Proven clinical use, maintains cellular integrity, reduces cold ischemia injury
Composite materials in unmanned aerial vehicles Lightweight design, higher endurance, improved stealth capabilities

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The organ preservation ecosystem includes medical device manufacturers, component suppliers, healthcare providers, regulatory agencies, and research institutions. Manufacturers work with OEMs and technology partners to develop innovations in optics, sensor integration, and AI-powered diagnostics. Hospitals, ambulatory surgical centers, and specialty clinics are the main end-users, boosting demand through increased use of minimally invasive procedures. Regulatory agencies like the FDA and EMA ensure product safety and compliance, shaping product design and timeframes for market release. Strategic alliances, R&D funding, and government healthcare investments further drive market growth. Additionally, medical training centers and professional organizations are vital for physician education, promoting clinical adoption and strengthening the overall ecosystem.

Organ Preservation Market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Organ Preservation Market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Organ Preservation Market, By Solution

In 2024, the UW solution segment held the largest share in the organ preservation market, mainly because of its effectiveness in flushing and preserving organs such as the kidneys, liver, and pancreas. Known as the standard for intracellular preservation, UW Solution’s wide acceptance comes from its inclusion of metabolically inert components like lactobionate and raffinose. These compounds help reduce tissue damage and improve the physiological function of organs, increasing transplant success rates compared to other preservation methods.

Organ Preservation Market, By Technique

The static cold storage segment held the largest market share in 2024. This traditional method is widely used and regarded as the standard for organ preservation because it can induce hypothermia, which helps decrease metabolic activity in donor organs. It is commonly used to preserve kidneys, liver, lungs, pancreas, and heart.

Organ Preservation Market, By Organ Type

In 2024, the kidney segment held the largest share of the organ preservation market. This dominance is due to the rising number of ESRD cases, with kidney transplantation as the preferred treatment option. This trend is expected to increase the number of kidney transplant procedures, resulting in a higher incidence of organ preservation for donor kidneys before transplantation into recipients.

Organ Preservation Market, By End User

In 2024, the organ transplant centers segment held the largest market share. This dominance is due to the global rise in the establishment of such centers, increased incidences of multi-organ failure, and government initiatives to promote organ donation.

REGION

Asia Pacific to be fastest-growing region in global Organ Preservation market during forecast period

Asia Pacific is expected to experience the fastest growth globally during the forecast period. This is mainly due to healthcare infrastructure growth, increased healthcare spending, and rapid adoption of minimally invasive surgeries in populous countries like China and India. These nations are investing significantly in improving diagnostic and surgical capabilities, especially addressing the growing incidence of chronic diseases. With universal insurance coverage, Japan’s well-established healthcare system ensures broad access to advanced endoscopic procedures. Additionally, increasing medical tourism, supportive government policies, and the growing use of minimally invasive technologies are driving market penetration, establishing Asia Pacific as a high-growth region in the organ preservation market.

Organ Preservation Market Region

Organ Preservation Market: COMPANY EVALUATION MATRIX

In the company evaluation matrix for the organ preservation market, XVIVO Perfusion AB (Star) leads with scale, extensive distribution, and a broad endoscopes portfolio. Transmedics (Emerging Leader) is gaining momentum with innovative organ preservation. Both XVIVO and Transmedics stand out by offering advanced organ preservation.

Organ Preservation Market Evaluation Matrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 0.24 BN
Revenue Forecast in 2030 (Value) USD 0.36 BN
Growth Rate 6.8%
Years Considered 2023–2030
Base year 2024
Forecast Period 2025–2030
Unit Considered Value (USD MN/BN), Volume (Thousand Units)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • Solution:
    • University of Wisconsin Solution
    • Custodial HTK
    • Perfadex
    • Other Solutions
  • Technique:
    • Static Cold Storage
    • Hypothermic Machine Perfusion
    • Normothermic Machine Perfusion
  • Organ Type:
    • Kidney
    • Liver
    • Lung
    • Heart
    • Pancreas
  • End User:
    • Organ Transplant Centers
    • Hospitals
    • Specialty Clinics
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa

WHAT IS IN IT FOR YOU: Organ Preservation Market REPORT CONTENT GUIDE

Organ Preservation Market Content Guide

RECENT DEVELOPMENTS

  • March 2025 : TransMedics expanded its National OCS Program (NOP) to additional US states, enhancing nationwide logistics and transplant coordination for heart, lung, and liver transplants through its proprietary normothermic technology platform.
  • January 2024 : X-Therma Inc. announced the successful completion of preclinical trials for its XT-ViVo organ preservation platform. The trials showed increased organ viability during extended cold storage, supporting the company’s plans for upcoming clinical validation and regulatory submissions.
  • January 2024 : Shanghai Genext Medical Technology partnered with a leading transplant hospital in Southeast Asia to pilot its next-generation perfusion machine for kidney preservation. The pilot aims to generate clinical evidence supporting a broader regional rollout.
  • May 2024 : BioLife Solutions introduced a new version of its HypoThermosol FRS preservation solution, designed for greater stability and longer shelf life. The product aims to enhance the preservation of cells, tissues, and organs during cold storage.
  • October 2023 : OrganOx Limited expanded clinical trials of its Metra normothermic liver perfusion device into additional European transplant centers. This strategy aims to accelerate adoption and facilitate regulatory submissions across regions.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
24
2
RESEARCH METHODOLOGY
 
 
 
28
3
EXECUTIVE SUMMARY
 
 
 
43
4
PREMIUM INSIGHTS
 
 
 
47
5
MARKET OVERVIEW
Booming organ donation initiatives and tech innovations drive market growth despite cost and supply challenges.
 
 
 
51
 
5.1
INTRODUCTION
 
 
 
 
5.2
MARKET DYNAMICS
 
 
 
 
 
5.2.1
DRIVERS
 
 
 
 
 
5.2.1.1
GROWING GERIATRIC POPULATION AND SUBSEQUENT GROWTH IN CASES OF MULTIPLE ORGAN FAILURE
 
 
 
 
5.2.1.2
INCREASING INITIATIVES TO PROMOTE PUBLIC AWARENESS AND ENCOURAGE ORGAN DONATION
 
 
 
 
5.2.1.3
RISING NUMBER OF ORGAN DONORS AND GROWING ADOPTION OF SOLID ORGAN TRANSPLANTATION PROCEDURES
 
 
 
5.2.2
RESTRAINTS
 
 
 
 
 
5.2.2.1
HIGH COST OF ORGAN TRANSPLANTATION
 
 
 
 
5.2.2.2
RELIGIOUS CONCERNS AND MISCONCEPTIONS ASSOCIATED WITH ORGAN DONATION
 
 
 
5.2.3
OPPORTUNITIES
 
 
 
 
 
5.2.3.1
GROWING HEALTHCARE INVESTMENTS
 
 
 
5.2.4
CHALLENGES
 
 
 
 
 
5.2.4.1
SIGNIFICANT GAP BETWEEN NUMBER OF ORGANS DONATED AND ORGANS REQUIRED ANNUALLY
 
 
 
 
5.2.4.2
DEVELOPMENT OF ARTIFICIAL ORGANS
 
 
5.3
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.4
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
5.6
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
5.7
PATENT ANALYSIS
 
 
 
 
 
 
5.7.1
PATENT PUBLICATION TRENDS FOR ORGAN PRESERVATION MARKET
 
 
 
 
5.7.2
TOP APPLICANTS (COMPANIES) OF ORGAN PRESERVATION PATENTS
 
 
 
 
5.7.3
JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN ORGAN PRESERVATION MARKET
 
 
 
5.8
TECHNOLOGY ANALYSIS
 
 
 
 
 
5.8.1
KEY TECHNOLOGIES
 
 
 
 
 
5.8.1.1
MACHINE PERFUSION
 
 
 
 
5.8.1.2
ORGAN PERFUSION
 
 
 
5.8.2
ADJACENT TECHNOLOGIES
 
 
 
 
 
5.8.2.1
CRYOPRESERVATION & VITRIFICATION
 
 
 
5.8.3
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
5.8.3.1
TEMPERATURE MONITORING DEVICES
 
 
5.9
TRADE ANALYSIS
 
 
 
 
 
 
5.9.1
IMPORT DATA
 
 
 
 
5.9.2
EXPORT DATA
 
 
 
5.10
KEY CONFERENCES AND EVENTS IN 2025–2026
 
 
 
 
5.11
REGULATORY LANDSCAPE
 
 
 
 
 
5.11.1
REGULATORY ANALYSIS
 
 
 
 
 
5.11.1.1
NORTH AMERICA
 
 
 
 
5.11.1.2
EUROPE
 
 
 
 
5.11.1.3
ASIA PACIFIC
 
 
 
 
5.11.1.4
LATIN AMERICA
 
 
 
 
5.11.1.5
MIDDLE EAST
 
 
 
 
5.11.1.6
AFRICA
 
 
 
5.11.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
5.12
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.12.1
THREAT FROM NEW ENTRANTS
 
 
 
 
5.12.2
THREAT FROM SUBSTITUTES
 
 
 
 
5.12.3
BARGAINING POWER OF SUPPLIERS
 
 
 
 
5.12.4
BARGAINING POWER OF BUYERS
 
 
 
 
5.12.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
5.13
KEY STAKEHOLDERS AND BUYING CRITERIA
 
 
 
 
 
 
5.13.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
5.13.2
BUYING CRITERIA
 
 
 
5.14
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
5.15
CASE STUDY ANALYSIS
 
 
 
 
5.16
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
5.17
REIMBURSEMENT SCENARIO
 
 
 
 
5.18
IMPACT OF AI ON ORGAN PRESERVATION MARKET
 
 
 
 
 
5.19
END USER EXPECTATIONS IN ORGAN PRESERVATION MARKET
 
 
 
 
5.20
IMPACT OF 2025 US TARIFFS
 
 
 
 
 
 
5.20.1
INTRODUCTION
 
 
 
 
5.20.2
KEY TARIFF RATES
 
 
 
 
5.20.3
PRICE IMPACT ANALYSIS
 
 
 
 
5.20.4
IMPACT ON END USERS
 
 
6
ORGAN PRESERVATION MARKET, BY SOLUTION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 6 Data Tables
 
 
 
81
 
6.1
INTRODUCTION
 
 
 
 
6.2
UNIVERSITY OF WISCONSIN
 
 
 
 
 
6.2.1
METABOLICALLY INERT SUBSTRATES ENABLE BETTER TRANSPLANTATION OUTCOMES
 
 
 
6.3
CUSTODIOL HTK
 
 
 
 
 
6.3.1
INDICATED FOR PERFUSION AND FLUSHING OF KIDNEYS, LIVER, PANCREAS, AND HEART
 
 
 
6.4
PERFADEX
 
 
 
 
 
6.4.1
LAUNCH OF PERFADEX PLUS TO DRIVE MARKET
 
 
 
6.5
OTHER SOLUTIONS
 
 
 
7
ORGAN PRESERVATION MARKET, BY TECHNIQUE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 9 Data Tables
 
 
 
89
 
7.1
INTRODUCTION
 
 
 
 
7.2
STATIC COLD STORAGE
 
 
 
 
 
7.2.1
MOST WIDELY ADOPTED ORGAN PRESERVATION TECHNIQUE
 
 
 
7.3
HYPOTHERMIC MACHINE PERFUSION
 
 
 
 
 
7.3.1
ADVANTAGES ASSOCIATED WITH HYPOTHERMIC MACHINE PERFUSION TO DRIVE DEMAND
 
 
 
7.4
NORMOTHERMIC MACHINE PERFUSION
 
 
 
 
 
7.4.1
PROVIDES VIABLE ENVIRONMENT FOR ORGAN PRESERVATION, VIABILITY, AND REPAIR PRIOR TO TRANSPLANTATION
 
 
8
ORGAN PRESERVATION MARKET, BY ORGAN TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 6 Data Tables
 
 
 
98
 
8.1
INTRODUCTION
 
 
 
 
8.2
KIDNEYS
 
 
 
 
 
8.2.1
MOST TRANSPLANTED ORGANS GLOBALLY
 
 
 
8.3
LIVER
 
 
 
 
 
8.3.1
RISING PREVALENCE OF LIVER DISEASE AND GROWING CASES OF LIVER FAILURE TO DRIVE DEMAND FOR LIVER TRANSPLANTATION PROCEDURES
 
 
 
8.4
LUNGS
 
 
 
 
 
8.4.1
GROWTH IN COPD INCIDENCE TO BOOST DEMAND FOR PRESERVATION TECHNIQUES AND PRODUCTS
 
 
 
8.5
HEART
 
 
 
 
 
8.5.1
ADVANCEMENTS IN HEART PRESERVATION TECHNIQUES TO DRIVE MARKET
 
 
 
8.6
OTHER ORGANS
 
 
 
9
ORGAN PRESERVATION MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 4 Data Tables
 
 
 
106
 
9.1
INTRODUCTION
 
 
 
 
9.2
ORGAN TRANSPLANT CENTERS
 
 
 
 
 
9.2.1
MAJOR END USERS OF ORGAN PRESERVATION SOLUTIONS
 
 
 
9.3
HOSPITALS
 
 
 
 
 
9.3.1
INCREASING CASES OF ACCIDENTAL INJURIES AND CHRONIC DISEASES TO DRIVE MARKET
 
 
 
9.4
SPECIALTY CLINICS
 
 
 
 
 
9.4.1
INCREASING PREVALENCE OF END-STAGE DISEASES AND ORGAN FAILURE TO DRIVE MARKET
 
 
10
ORGAN PRESERVATION MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 14 Countries | 107 Data Tables.
 
 
 
111
 
10.1
INTRODUCTION
 
 
 
 
10.2
NORTH AMERICA
 
 
 
 
 
10.2.1
MACROECONOMIC OUTLOOK
 
 
 
 
10.2.2
US
 
 
 
 
 
10.2.2.1
GROWING CASES OF ORGAN FAILURE AND UNDERLYING DISEASES TO DRIVE DEMAND
 
 
 
10.2.3
CANADA
 
 
 
 
 
10.2.3.1
IMPROVED ORGAN DONATION RATES TO DRIVE GROWTH
 
 
10.3
EUROPE
 
 
 
 
 
10.3.1
MACROECONOMIC OUTLOOK
 
 
 
 
10.3.2
GERMANY
 
 
 
 
 
10.3.2.1
GROWING PATIENT POPULATION TO DRIVE DEMAND
 
 
 
10.3.3
FRANCE
 
 
 
 
 
10.3.3.1
INCREASING NUMBER OF ORGAN TRANSPLANTS AND ORGAN DONOR REGISTRATIONS TO DRIVE GROWTH
 
 
 
10.3.4
UK
 
 
 
 
 
10.3.4.1
INCREASING DISEASE/DISORDER PREVALENCE AND FAVORABLE REGULATIONS TO DRIVE DEMAND
 
 
 
10.3.5
SPAIN
 
 
 
 
 
10.3.5.1
HIGH DONATION RATES TO DRIVE GROWTH
 
 
 
10.3.6
ITALY
 
 
 
 
 
10.3.6.1
SURGE IN DONOR NUMBERS AND TECHNOLOGICAL INNOVATION TO DRIVE GROWTH
 
 
 
10.3.7
REST OF EUROPE
 
 
 
10.4
ASIA PACIFIC
 
 
 
 
 
10.4.1
MACROECONOMIC OUTLOOK
 
 
 
 
10.4.2
CHINA
 
 
 
 
 
10.4.2.1
GROWING AWARENESS AND ADOPTION OF LAWS FAVORING ORGAN DONATION TO DRIVE MARKET
 
 
 
10.4.3
JAPAN
 
 
 
 
 
10.4.3.1
NATIONWIDE AWARENESS CAMPAIGNS AND PROMOTED OPT-IN REGISTRATION TO DRIVE GROWTH
 
 
 
10.4.4
INDIA
 
 
 
 
 
10.4.4.1
GROWING NUMBER OF INITIATIVES TO INCREASE PUBLIC AWARENESS TO DRIVE MARKET
 
 
 
10.4.5
AUSTRALIA
 
 
 
 
 
10.4.5.1
ENHANCED HOSPITAL-BASED DONATION PROGRAMS TO DRIVE GROWTH
 
 
 
10.4.6
SOUTH KOREA
 
 
 
 
 
10.4.6.1
IMPROVED DONOR REGISTRATION SYSTEMS TO DRIVE GROWTH
 
 
 
10.4.7
REST OF ASIA PACIFIC
 
 
 
10.5
LATIN AMERICA
 
 
 
 
 
10.5.1
MACROECONOMIC OUTLOOK
 
 
 
 
10.5.2
BRAZIL
 
 
 
 
 
10.5.2.1
DIGITALIZATION OF DONOR REGISTRIES TO DRIVE GROWTH
 
 
 
10.5.3
MEXICO
 
 
 
 
 
10.5.3.1
ORGAN DONATION EFFORTS SUPPORTED BY CENTRALIZED TRANSPLANT REGISTRY AND NATIONAL COORDINATION TO DRIVE GROWTH
 
 
 
10.5.4
REST OF LATIN AMERICA
 
 
 
10.6
MIDDLE EAST & AFRICA
 
 
 
 
 
10.6.1
IMPLEMENTATION OF GOVERNMENT INITIATIVES AND POLICIES TO DRIVE MARKET
 
 
 
 
10.6.2
MACROECONOMIC OUTLOOK
 
 
 
10.7
GCC COUNTRIES
 
 
 
 
 
10.7.1
STRONG ORGAN PRESERVATION THROUGH INCENTIVES, INFRASTRUCTURE, AND PUBLIC AWARENESS TO DRIVE GROWTH
 
 
 
 
10.7.2
MACROECONOMIC OUTLOOK
 
 
11
COMPETITIVE LANDSCAPE
Identify key players' winning strategies and market shares shaping the competitive landscape.
 
 
 
172
 
11.1
OVERVIEW
 
 
 
 
11.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
11.3
REVENUE ANALYSIS, 2022–2024
 
 
 
 
 
11.4
MARKET SHARE ANALYSIS
 
 
 
 
 
11.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
 
 
 
 
 
 
11.5.1
STARS
 
 
 
 
11.5.2
EMERGING LEADERS
 
 
 
 
11.5.3
PERVASIVE PLAYERS
 
 
 
 
11.5.4
PARTICIPANTS
 
 
 
 
11.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
 
 
 
 
 
11.5.5.1
COMPANY FOOTPRINT
 
 
 
 
11.5.5.2
SOLUTION FOOTPRINT
 
 
 
 
11.5.5.3
TECHNIQUE FOOTPRINT
 
 
 
 
11.5.5.4
END USER FOOTPRINT
 
 
 
 
11.5.5.5
REGION FOOTPRINT
 
 
11.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
 
 
 
 
 
 
11.6.1
PROGRESSIVE COMPANIES
 
 
 
 
11.6.2
RESPONSIVE COMPANIES
 
 
 
 
11.6.3
DYNAMIC COMPANIES
 
 
 
 
11.6.4
STARTING BLOCKS
 
 
 
 
11.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
 
 
 
 
 
11.6.5.1
LIST OF KEY STARTUPS/SMES
 
 
 
 
11.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
11.7
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
 
11.7.1
COMPANY VALUATION
 
 
 
 
11.7.2
FINANCIAL METRICS
 
 
 
11.8
BRAND/PRODUCT COMPARISON
 
 
 
 
 
11.9
COMPETITIVE SCENARIO
 
 
 
 
 
11.9.1
PRODUCT LAUNCHES & APPROVALS
 
 
 
 
11.9.2
DEALS
 
 
 
 
11.9.3
OTHER DEVELOPMENTS
 
 
12
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
191
 
12.1
KEY PLAYERS
 
 
 
 
 
12.1.1
PARAGONIX TECHNOLOGIES, INC.
 
 
 
 
 
12.1.1.1
BUSINESS OVERVIEW
 
 
 
 
12.1.1.2
PRODUCTS OFFERED
 
 
 
 
12.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
12.1.1.4
MNM VIEW
 
 
 
12.1.2
XVIVO PERFUSION AB
 
 
 
 
12.1.3
DR. FRANZ KÖHLER CHEMIE GMBH
 
 
 
 
12.1.4
ESSENTIAL PHARMACEUTICALS, LLC (SUBSIDIARY OF ACCORD HEALTHCARE)
 
 
 
 
12.1.5
TRANSMEDICS, INC.
 
 
 
 
12.1.6
ORGANOX LIMITED
 
 
 
 
12.1.7
21ST CENTURY MEDICINE
 
 
 
 
12.1.8
BIOLIFE SOLUTIONS, INC.
 
 
 
 
12.1.9
BRIDGE TO LIFE LIMITED
 
 
 
 
12.1.10
WATERS MEDICAL SYSTEMS LLC
 
 
 
12.2
OTHER PLAYERS
 
 
 
 
 
12.2.1
SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.
 
 
 
 
12.2.2
PRESERVATION SOLUTIONS, INC.
 
 
 
 
12.2.3
CARNAMEDICA
 
 
 
 
12.2.4
TRANSPLANT BIOMEDICALS
 
 
 
 
12.2.5
INSTITUT GEORGES LOPEZ
 
 
 
 
12.2.6
GLOBAL TRANSPLANT SOLUTIONS
 
 
 
 
12.2.7
AVIONORD
 
 
 
 
12.2.8
ORGAN PRESERVATION SOLUTIONS LTD.
 
 
 
 
12.2.9
EBERS
 
 
 
 
12.2.10
S.A.L.F.
 
 
 
 
12.2.11
BIOCHEFA
 
 
 
 
12.2.12
VASCULAR PERFUSION SOLUTIONS, INC.
 
 
 
 
12.2.13
TX INNOVATIONS
 
 
 
 
12.2.14
TAIYO NIPPON SANSO CORPORATION
 
 
 
 
12.2.15
X-THERMA, INC.
 
 
13
APPENDIX
 
 
 
227
 
13.1
DISCUSSION GUIDE
 
 
 
 
13.2
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
13.3
AVAILABLE CUSTOMIZATIONS
 
 
 
 
13.4
RELATED REPORTS
 
 
 
 
13.5
AUTHOR DETAILS
 
 
 
LIST OF TABLES
 
 
 
 
 
TABLE 1
EXCHANGE RATES UTILIZED FOR CONVERSION TO USD, 2021–2024
 
 
 
 
TABLE 2
GROWTH IN GERIATRIC POPULATION (ABOVE 65 AGE GROUP), BY REGION, 2019 VS. 2050 (MILLION)
 
 
 
 
TABLE 3
NUMBER OF ORGAN DONATIONS, 2020
 
 
 
 
TABLE 4
COST OF SURGICAL PROCEDURES: US VS. INDIA (USD)
 
 
 
 
TABLE 5
AVERAGE SELLING PRICE RANGE OF ORGAN PRESERVATION SOLUTIONS, BY KEY PLAYERS, 2023–2024
 
 
 
 
TABLE 6
AVERAGE SELLING PRICE RANGE OF CUSTODIOL SOLUTIONS FOR ORGAN PRESERVATION SOLUTIONS IN KEY REGIONS, 2022–2024
 
 
 
 
TABLE 7
ORGAN PRESERVATION MARKET: LIST OF MAJOR PATENTS, 2020–2021
 
 
 
 
TABLE 8
IMPORT DATA OF ORGAN PRESERVATION FOR HS CODE 300640, BY COUNTRY, 2019–2023 (USD THOUSAND)
 
 
 
 
TABLE 9
EXPORT DATA OF ORGAN PRESERVATION FOR HS CODE 300640, BY COUNTRY, 2019–2023 (USD THOUSAND)
 
 
 
 
TABLE 10
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 11
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 12
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 13
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 14
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 SOLUTIONS (%)
 
 
 
 
TABLE 15
KEY BUYING CRITERIA FOR TOP 3 SOLUTIONS
 
 
 
 
TABLE 16
CASE STUDY 1: PRESERVATION OF MARGINAL LIVER USING NORMOTHERMIC MACHINE PERFUSION (NMP)
 
 
 
 
TABLE 17
CASE STUDY 2: HYPOTHERMIC MACHINE PERFUSION FOR EXTENDED CRITERIA KIDNEY TRANSPLANT
 
 
 
 
TABLE 18
CASE STUDY 3: USE OF PORTABLE NORMOTHERMIC PERFUSION FOR HEART TRANSPLANTATION
 
 
 
 
TABLE 19
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
TABLE 20
ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 21
ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 22
ORGAN PRESERVATION MARKET FOR UW SOLUTIONS, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 23
ORGAN PRESERVATION MARKET FOR CUSTODIOL HTK SOLUTIONS, BY COUNTRY/ REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 24
ORGAN PRESERVATION MARKET FOR PERFADEX SOLUTIONS, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 25
OTHER ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 26
COMPARISON OF METHODS USED FOR ORGAN PRESERVATION
 
 
 
 
TABLE 27
ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 28
ORGAN PRESERVATION TECHNIQUE MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 29
STATIC COLD STORAGE: ADVANTAGES AND DISADVANTAGES
 
 
 
 
TABLE 30
ORGAN PRESERVATION MARKET FOR STATIC COLD STORAGE, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 31
HYPOTHERMIC MACHINE PERFUSION: ADVANTAGES AND DISADVANTAGES
 
 
 
 
TABLE 32
ORGAN PRESERVATION MARKET FOR HYPOTHERMIC MACHINE PERFUSION, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 33
NORMOTHERMIC MACHINE PERFUSION: ADVANTAGES AND DISADVANTAGES
 
 
 
 
TABLE 34
ORGAN PRESERVATION MARKET FOR NORMOTHERMIC MACHINE PERFUSION, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 35
ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 36
KIDNEY PRESERVATION MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 37
LIVER PRESERVATION MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 38
LUNG PRESERVATION MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 39
HEART PRESERVATION MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 40
OTHER ORGAN PRESERVATION MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 41
ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 42
ORGAN PRESERVATION MARKET FOR ORGAN TRANSPLANT CENTERS, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 43
ORGAN PRESERVATION MARKET FOR HOSPITALS, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 44
ORGAN PRESERVATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 45
ORGAN PRESERVATION MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 46
NORTH AMERICA: ORGAN PRESERVATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 47
NORTH AMERICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 48
NORTH AMERICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 49
NORTH AMERICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 50
NORTH AMERICA: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 51
US: KEY MACROINDICATORS
 
 
 
 
TABLE 52
WAITING LIST FOR ORGAN TRANSPLANTS AS OF JANUARY 2022
 
 
 
 
TABLE 53
US: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 54
US: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 55
US: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 56
US: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 57
CANADA: KEY MACROINDICATORS
 
 
 
 
TABLE 58
CANADA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 59
CANADA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 60
CANADA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 61
CANADA: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 62
EUROPE: ORGAN PRESERVATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 63
EUROPE: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 64
EUROPE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 65
EUROPE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 66
EUROPE: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 67
GERMANY: KEY MACROINDICATORS
 
 
 
 
TABLE 68
GERMANY: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 69
GERMANY: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 70
GERMANY: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 71
GERMANY: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 72
FRANCE: KEY MACROINDICATORS
 
 
 
 
TABLE 73
FRANCE: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 74
FRANCE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 75
FRANCE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 76
FRANCE: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 77
UK: KEY MACROINDICATORS
 
 
 
 
TABLE 78
TOTAL NUMBER OF PATIENTS ON ACTIVE ORGAN TRANSPLANT WAITING LIST IN UK (AS OF APRIL 8, 2021)
 
 
 
 
TABLE 79
UK: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 80
UK: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 81
UK: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 82
UK: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 83
SPAIN: KEY MACROINDICATORS
 
 
 
 
TABLE 84
SPAIN: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 85
SPAIN: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 86
SPAIN: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 87
SPAIN: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 88
ITALY: KEY MACROINDICATORS
 
 
 
 
TABLE 89
ITALY: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 90
ITALY: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 91
ITALY: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 92
ITALY: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 93
REST OF EUROPE: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 94
REST OF EUROPE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 95
REST OF EUROPE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 96
REST OF EUROPE: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 97
ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 98
ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 99
ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 100
ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 101
ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 102
CHINA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 103
CHINA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 104
CHINA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 105
CHINA: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 106
TOTAL NUMBER OF PATIENTS ON ORGAN TRANSPLANT WAITING LIST IN JAPAN (AS OF MARCH 31, 2021)
 
 
 
 
TABLE 107
JAPAN: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 108
JAPAN: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 109
JAPAN: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 110
JAPAN: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 111
INDIA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 112
INDIA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 113
INDIA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 114
INDIA: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 115
AUSTRALIA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 116
AUSTRALIA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 117
AUSTRALIA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 118
AUSTRALIA: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 119
SOUTH KOREA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 120
SOUTH KOREA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 121
SOUTH KOREA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 122
SOUTH KOREA: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 123
REST OF ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 124
REST OF ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 125
REST OF ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 126
REST OF ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 127
LATIN AMERICA: ORGAN PRESERVATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 128
LATIN AMERICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 129
LATIN AMERICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 130
LATIN AMERICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 131
LATIN AMERICA: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 132
BRAZIL: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 133
BRAZIL: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 134
BRAZIL: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 135
BRAZIL: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 136
MEXICO: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 137
MEXICO: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 138
MEXICO: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 139
MEXICO: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 140
REST OF LATIN AMERICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 141
REST OF LATIN AMERICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 142
REST OF LATIN AMERICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 143
REST OF LATIN AMERICA: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 144
MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 145
MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 146
MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 147
MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 148
GCC COUNTRIES: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 149
GCC COUNTRIES: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 150
GCC COUNTRIES: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 151
GCC COUNTRIES: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 152
OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ORGAN PRESERVATION MARKET
 
 
 
 
TABLE 153
ORGAN PRESERVATION MARKET: DEGREE OF COMPETITION
 
 
 
 
TABLE 154
ORGAN PRESERVATION MARKET: SOLUTION FOOTPRINT
 
 
 
 
TABLE 155
ORGAN PRESERVATION MARKET: TECHNIQUE FOOTPRINT
 
 
 
 
TABLE 156
ORGAN PRESERVATION MARKET: END USER FOOTPRINT
 
 
 
 
TABLE 157
ORGAN PRESERVATION MARKET: REGION FOOTPRINT
 
 
 
 
TABLE 158
ORGAN PRESERVATION MARKET: LIST OF KEY STARTUPS/SMES
 
 
 
 
TABLE 159
ORGAN PRESERVATION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
TABLE 160
ORGAN PRESERVATION MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JUNE 2025
 
 
 
 
TABLE 161
ORGAN PRESERVATION MARKET: DEALS, JANUARY 2021–JUNE 2025
 
 
 
 
TABLE 162
ORGAN PRESERVATION MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2025
 
 
 
 
TABLE 163
PARAGONIX TECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 164
PARAGONIX TECHNOLOGIES, INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 165
PARAGONIX TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025
 
 
 
 
TABLE 166
PARAGONIX TECHNOLOGIES, INC.: DEALS, JANUARY 2021–MAY 2025
 
 
 
 
TABLE 167
PARAGONIX TECHNOLOGIES, INC.: OTHER DEVELOPMENTS, JANUARY 2021–MAY 2025
 
 
 
 
TABLE 168
XVIVO PERFUSION AB: COMPANY OVERVIEW
 
 
 
 
TABLE 169
XVIVO PERFUSION AB: PRODUCTS OFFERED
 
 
 
 
TABLE 170
XVIVO PERFUSION AB: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2025
 
 
 
 
TABLE 171
XVIVO PERFUSION AB: DEALS, JANUARY 2021–MAY 2025
 
 
 
 
TABLE 172
DR. FRANZ KÖHLER CHEMIE GMBH: COMPANY OVERVIEW
 
 
 
 
TABLE 173
DR. FRANZ KÖHLER CHEMIE GMBH: PRODUCTS OFFERED
 
 
 
 
TABLE 174
ESSENTIAL PHARMACEUTICALS, LLC: COMPANY OVERVIEW
 
 
 
 
TABLE 175
ESSENTIAL PHARMACEUTICALS, LLC: PRODUCTS OFFERED
 
 
 
 
TABLE 176
TRANSMEDICS, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 177
TRANSMEDICS, INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 178
TRANSMEDICS, INC.: PRODUCT LAUNCHES & APPROVALS
 
 
 
 
TABLE 179
TRANSMEDICS, INC.: DEALS
 
 
 
 
TABLE 180
ORGANOX LIMITED: COMPANY OVERVIEW
 
 
 
 
TABLE 181
ORGANOX LIMITED: PRODUCTS OFFERED
 
 
 
 
TABLE 182
ORGANOX LIMITED: PRODUCT LAUNCHES & APPROVALS
 
 
 
 
TABLE 183
ORGANOX LIMITED: DEALS
 
 
 
 
TABLE 184
21ST CENTURY MEDICINE: COMPANY OVERVIEW
 
 
 
 
TABLE 185
21ST CENTURY MEDICINE: PRODUCTS OFFERED
 
 
 
 
TABLE 186
BIOLIFE SOLUTIONS, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 187
BIOLIFE SOLUTIONS, INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 188
BIOLIFE SOLUTIONS, INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025
 
 
 
 
TABLE 189
BIOLIFE SOLUTIONS, INC.: DEALS, JANUARY 2021–MAY 2025
 
 
 
 
TABLE 190
BRIDGE TO LIFE LIMITED: COMPANY OVERVIEW
 
 
 
 
TABLE 191
BRIDGE TO LIFE LIMITED: PRODUCTS OFFERED
 
 
 
 
TABLE 192
BRIDGE TO LIFE LIMITED: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2025
 
 
 
 
TABLE 193
BRIDGE TO LIFE LIMITED: DEALS, JANUARY 2021–MAY 2025
 
 
 
 
TABLE 194
WATERS MEDICAL SYSTEMS LLC: COMPANY OVERVIEW
 
 
 
 
TABLE 195
WATERS MEDICAL SYSTEMS LLC: PRODUCTS OFFERED
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
FIGURE 1
ORGAN PRESERVATION MARKET: RESEARCH DESIGN
 
 
 
 
FIGURE 2
LIST OF PRIMARY SOURCES
 
 
 
 
FIGURE 3
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
 
 
 
 
FIGURE 4
BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
FIGURE 5
BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
FIGURE 6
SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
 
 
 
 
FIGURE 7
REVENUE SHARE ANALYSIS ILLUSTRATION: XVIVO PERFUSION AB (2024)
 
 
 
 
FIGURE 8
ILLUSTRATIVE EXAMPLE OF PROCEDURE-BASED MARKET ESTIMATION
 
 
 
 
FIGURE 9
SUPPLY-SIDE MARKET SIZE ESTIMATION: ORGAN PRESERVATION MARKET (2024)
 
 
 
 
FIGURE 10
TOP-DOWN APPROACH
 
 
 
 
FIGURE 11
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN ORGAN PRESERVATION MARKET (2025–2030)
 
 
 
 
FIGURE 12
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
 
 
 
 
FIGURE 13
DATA TRIANGULATION METHODOLOGY
 
 
 
 
FIGURE 14
ORGAN PRESERVATION MARKET, BY SOLUTION, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 15
ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 16
ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 17
ORGAN PRESERVATION MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 18
GEOGRAPHIC ANALYSIS OF ORGAN PRESERVATION MARKET
 
 
 
 
FIGURE 19
RISING NUMBER OF SOLID ORGAN TRANSPLANTS TO DRIVE ORGAN PRESERVATION MARKET
 
 
 
 
FIGURE 20
UNIVERSITY OF WISCONSIN SOLUTION AND CHINA SEGMENTS ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC ORGAN PRESERVATION MARKET IN 2024
 
 
 
 
FIGURE 21
CHINA TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD
 
 
 
 
FIGURE 22
NORTH AMERICA TO DOMINATE ORGAN PRESERVATION MARKET TILL 2030
 
 
 
 
FIGURE 23
EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
 
 
 
 
FIGURE 24
ORGAN PRESERVATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
FIGURE 25
ORGAN PRESERVATION MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
FIGURE 26
ORGAN PRESERVATION MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
FIGURE 27
SUPPLY CHAIN ANALYSIS: ORGAN PRESERVATION MARKET (2024)
 
 
 
 
FIGURE 28
TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR ORGAN PRESERVATION SOLUTIONS (JANUARY 2014–APRIL 2025)
 
 
 
 
FIGURE 29
JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR ORGAN PRESERVATION PATENTS, 2014–2025
 
 
 
 
FIGURE 30
ORGAN PRESERVATION MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
FIGURE 31
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 SOLUTIONS
 
 
 
 
FIGURE 32
KEY BUYING CRITERIA FOR TOP 3 SOLUTIONS
 
 
 
 
FIGURE 33
TRENDS AND DISRUPTIONS DISRUPTING CUSTOMER BUSINESS IN ORGAN PRESERVATION MARKET
 
 
 
 
FIGURE 34
ORGAN PRESERVATION MARKET: INVESTMENT AND FUNDING SCENARIO, 2021–2024
 
 
 
 
FIGURE 35
ORGAN PRESERVATION MARKET: AI INTEGRATION
 
 
 
 
FIGURE 38
ASIA PACIFIC: ORGAN PRESERVATION MARKET SNAPSHOT
 
 
 
 
FIGURE 39
REVENUE ANALYSIS OF KEY PLAYERS IN ORGAN PRESERVATION MARKET (2021−2024)
 
 
 
 
FIGURE 40
MARKET SHARE ANALYSIS OF KEY PLAYERS (2024)
 
 
 
 
FIGURE 41
ORGAN PRESERVATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
 
 
 
 
FIGURE 42
ORGAN PRESERVATION MARKET: COMPANY FOOTPRINT
 
 
 
 
FIGURE 43
ORGAN PRESERVATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
 
 
 
 
FIGURE 44
YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
FIGURE 45
EV/EBITDA OF KEY VENDORS
 
 
 
 
FIGURE 46
ORGAN PRESERVATION MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
FIGURE 47
XVIVO PERFUSION AB: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 48
TRANSMEDICS, INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 49
BIOLIFE SOLUTIONS, INC.: COMPANY SNAPSHOT (2024)
 
 
 
 

Methodology

The study involved four major activities to estimate the current size of the organ preservation market—exhaustive secondary research collected information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various sources were utilized to identify and gather information to study the organ preservation market. These sources included company annual reports, press releases, investor presentations, white papers, certified publications, and articles by recognized authors. We also consulted reputable websites, regulatory bodies, and databases such as D&B Hoovers, Bloomberg Business, and Factiva.

This research aimed to gather crucial information about the leading companies in the industry, market classification, and segmentation based on industry trends down to the most detailed levels, including geographic markets. Additionally, we focused on key developments related to the market. Through this secondary research, a database of key industry leaders was created.

Primary Research

Extensive primary research was conducted after gathering information about the organ preservation market through secondary research. Several primary interviews were held with market experts from both the demand and supply sides across major regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), Directors of business development, marketing, product development/innovation teams, and other key executives from manufacturers and distributors operating in the organ preservation market, as well as key opinion leaders.

The following is a breakdown of the primary respondents:

Organ Preservation Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The research methodology used to estimate the size of the organ preservation market includes the following details.

The market sizing was undertaken from the global side.

Country-level Analysis: The size of the organ preservation market was obtained from the annual presentations of leading players and secondary data available in the public domain. Shares of products in the overall organ preservation market were obtained from secondary data and validated by primary participants to arrive at the total organ preservation market. Primary participants further validated the numbers.

Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

Industry experts contacted during primary research validated the assumptions and approaches at each point. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall organ preservation market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Global Organ Preservation Market Size: Bottom-up Approach & Top-down Approach

Organ Preservation Market

Data Triangulation

The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and determine each market segment's and subsegment's exact statistics. The data was triangulated by studying various factors and trends from both the demand and supply sides in the organ preservation market.

Market Definition

Organ preservation solutions are used to protect and preserve the viability of organs during organ transplantation. Utilizing distinct methodologies, organ preservation starts with the surgical removal of the donor organ and concludes with its placement in the recipient. Various solutions (such as the University of Wisconsin solution and Custodiol HTK) and techniques (such as static cold storage and hypothermic machine perfusion) are used to preserve organs.

Stakeholders

  • Association of Organ Procurement Organizations (AOPO)
  • American Transplant Congress (ATC)
  • United Network for Organ Sharing (UNOS)
  • Network & Alliance of Transplant Coordinators (NATCO)
  • Consortium for Organ Preservation in Europe (COPE)
  • European Society for Organ Transplantation (ESOT)
  • Asian Society of Transplantation (AST)
  • National Health Service (UK NHS)
  • International Registry on Organ Donation and Transplantation (IRODaT)
  • Global Observatory on Donation and Transplants (GODT)
  • National Institutes of Health (NIH)
  • World Health Organization (WHO)
  • Organisation for Economic Co-operation and Development (OECD)
  • Centers for Disease Control and Prevention (CDC)
  • Annual Reports/SEC Filings, Investor Presentations, and Press Releases of Key Players
  • White Papers, Journals/Magazines, and News Articles

Report Objectives

  • To define, describe, and forecast the organ preservation market based on solution, technique, organ type, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall organ preservation market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
  • To estimate the market size and growth potential of the market segments with respect to six regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
  • To profile the key players operating in the organ preservation market and comprehensively analyze their revenue shares and core competencies2
  • To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, expansions, joint ventures, and acquisitions in the organ preservation market
  • To benchmark players in the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business strategy and product offering

 

Key Questions Addressed by the Report

Which are the top industry players in the global organ preservation market?

The top market players include Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr. Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut Georges Lopez (France), and Global Transplant Solutions (US).

Which global organ preservation solutions have been included in this report?

University of Wisconsin Solution, Custodial HTK, Perfadex, and Other Solutions (Celsior and Euro-collins).

Which geographical region dominates in the global organ preservation market?

North America dominates the market due to a high incidence of chronic diseases, increasing demand for transplants, strong presence of industry players, and advanced healthcare infrastructure.

What strategies are adopted by the top market players to penetrate emerging regions?

Key strategies include partnerships, expansions, distribution agreements, product launches, and product approvals.

What is the expected addressable market value of the organ preservation market in the coming years between 2025 and 2030?

The market is projected to reach USD 0.3 billion by 2030 from USD 0.2 billion in 2025, growing at a CAGR of 6.8%.

TABLE OF CONTENTS

METHODOLOGY

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Organ Preservation Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Organ Preservation Market

Marta

May, 2022

We have an investigation at the University on Organ Preservation Market and we want to analyze if it has potential. Thank you.

Benjamin

May, 2022

Interest in the organ preservation market, specifically organ preservation solutions.

Jacob

Oct, 2022

I want more detailed information on the market size estimation methodologies followed for the study of Organ Preservation Market.

DMCA.com Protection Status